Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RGCC | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | KCTD6 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | FXYD5 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | NABP2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | P2RX3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | GLT8D2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | STK10 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | IL12RB2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | WTIP | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | JPH2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |